NV
BATS · NVOH
Precidian ETFs Trust Novo Nordi
Healthcare · Medical - Pharmaceuticals
$23.43
Up+$0.32 (+1.37%)
Updated Sep 14, 2026, 9:52 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.46M
- P/E ratio
- —
- Dividend yield
- 2.79%
- 52-week range
- $19.00 – $28.16
- Volume
- 285.28
- Avg. volume
- 3.49K
Price performance
NVOH price history
1M range · 19 trading sessions · Daily adjusted prices
NVOH closed at $23.43 after 19 trading sessions, down 4.07% for the selected period.
- Last close
- $23.43
- Period change
- -4.07%
- Period low
- $23.43
- Period high
- $26.37
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $23.4261 | $23.4261 | $23.4261 | $23.4261 | 285.28 |
| Sep 10, 2026 | $24.16 | $24.17 | $23.954 | $23.954 | 796.89 |
| Sep 9, 2026 | $24.40 | $24.52 | $24.1612 | $24.1612 | 1.7K |
| Sep 8, 2026 | $24.63 | $24.78 | $24.51 | $24.5207 | 853.19 |
| Sep 4, 2026 | $25.10 | $25.2595 | $25.05 | $25.2595 | 1K |
| Sep 3, 2026 | $25.85 | $25.85 | $25.38 | $25.6877 | 2.98K |
| Sep 2, 2026 | $25.49 | $25.49 | $25.28 | $25.4618 | 1.14K |
| Sep 1, 2026 | $24.73 | $24.73 | $24.5091 | $24.5091 | 293.56 |
| Aug 31, 2026 | $24.50 | $24.69 | $24.50 | $24.5859 | 969.08 |
| Aug 28, 2026 | $24.96 | $24.96 | $24.73 | $24.7751 | 6.93K |
| Aug 27, 2026 | $24.85 | $25.02 | $24.75 | $24.9897 | 1.64K |
| Aug 26, 2026 | $25.69 | $25.69 | $25.4775 | $25.4775 | 592.38 |
| Aug 25, 2026 | $25.95 | $26.37 | $25.70 | $26.37 | 1.53K |
| Aug 24, 2026 | $25.33 | $25.35 | $25.33 | $25.35 | 499.03 |
| Aug 21, 2026 | $25.24 | $25.36 | $25.21 | $25.2397 | 986.98 |
| Aug 20, 2026 | $25.00 | $25.05 | $24.3201 | $24.9612 | 1.04K |
| Aug 19, 2026 | $25.30 | $25.42 | $25.0553 | $25.0553 | 1.31K |
| Aug 18, 2026 | $24.63 | $24.8729 | $24.63 | $24.8729 | 318.6 |
| Aug 17, 2026 | $24.56 | $24.66 | $24.4193 | $24.4193 | 725.64 |
Latest NVOH news
The latest Smart Investors Daily articles mentioning NVOH.
Stock researchCompany · Financials
Loading stock research…
